News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
674,994 Results
Type
Article (57731)
Company Profile (80)
Press Release (617167)
Multimedia
Podcasts (121)
Webinars (21)
Section
Business (175411)
Career Advice (2738)
Deals (32955)
Drug Delivery (138)
Drug Development (76656)
Employer Resources (159)
FDA (15305)
Job Trends (14133)
News (308015)
Policy (29934)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (2739)
Academic (2)
Accelerated approval (46)
Adcomms (32)
Allergies (172)
Alliances (44062)
ALS (204)
Alzheimer's disease (1711)
Antibody-drug conjugate (ADC) (431)
Approvals (15697)
Artificial intelligence (679)
Autoimmune disease (296)
Automation (53)
Bankruptcy (300)
Best Places to Work (10935)
BIOSECURE Act (20)
Biosimilars (206)
Biotechnology (55)
Bladder cancer (187)
Brain cancer (75)
Breast cancer (734)
Cancer (5728)
Cardiovascular disease (460)
Career advice (2346)
Career pathing (47)
CAR-T (348)
CDC (60)
Celiac Disease (3)
Cell therapy (933)
Cervical cancer (46)
Clinical research (66853)
Collaboration (2040)
Company closure (7)
Compensation (844)
Complete response letters (84)
COVID-19 (2672)
CRISPR (111)
C-suite (1184)
Cystic fibrosis (152)
Data (7708)
Decentralized trials (2)
Denatured (47)
Depression (165)
Dermatology (79)
Diabetes (552)
Diagnostics (6790)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (317)
Drug pricing (224)
Drug shortages (28)
Duchenne muscular dystrophy (259)
Earnings (65979)
Editorial (70)
Employer branding (19)
Employer resources (141)
Events (101950)
Executive appointments (1139)
FDA (19022)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1708)
Gene editing (240)
Generative AI (59)
Gene therapy (695)
GLP-1 (995)
Government (4905)
Grass and pollen (8)
Guidances (404)
Healthcare (18565)
HIV (79)
Huntington's disease (48)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (90)
Immunology and inflammation (259)
Immuno-oncology (93)
Indications (180)
Infectious disease (2999)
Inflammatory bowel disease (216)
Inflation Reduction Act (15)
Influenza (131)
Intellectual property (284)
Interviews (530)
IPO (15115)
IRA (59)
Job creations (3498)
Job search strategy (1932)
JPM (64)
Kidney cancer (20)
Labor market (90)
Layoffs (611)
Leadership (44)
Legal (6736)
Liver cancer (94)
Longevity (29)
Lung cancer (745)
Lymphoma (418)
Machine learning (57)
Management (54)
Manufacturing (985)
MASH (187)
Medical device (13157)
Medtech (13275)
Mergers & acquisitions (19110)
Metabolic disorders (1440)
mRNA (210)
Multiple sclerosis (178)
NASH (16)
Neurodegenerative disease (391)
Neuropsychiatric disorders (104)
Neuroscience (3170)
Neurotech (1)
NextGen: Class of 2026 (6448)
Non-profit (4487)
Now hiring (28)
Obesity (659)
Opinion (328)
Ovarian cancer (218)
Pain (252)
Pancreatic cancer (298)
Parkinson's disease (344)
Partnered (34)
Patents (590)
Patient recruitment (688)
Peanut (63)
People (61193)
Pharmaceutical (18)
Pharmacy benefit managers (29)
Phase 1 (21159)
Phase 2 (29560)
Phase 3 (21505)
Pipeline (8519)
Policy (335)
Postmarket research (2356)
Preclinical (8911)
Press Release (64)
Prostate cancer (302)
Psychedelics (49)
Radiopharmaceuticals (320)
Rare diseases (1044)
Real estate (6106)
Recruiting (68)
Regulatory (23592)
Reports (44)
Research institute (2571)
Resumes & cover letters (408)
Rett syndrome (40)
RNA editing (20)
RSV (78)
Schizophrenia (172)
Series A (294)
Series B (205)
Service/supplier (8)
Sickle cell disease (110)
Special edition (21)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3438)
State (1)
Stomach cancer (13)
Supply chain (113)
Tariffs (76)
The Weekly (71)
Vaccines (1063)
Venture capital (101)
Weight loss (416)
Women's health (113)
Worklife (24)
Date
Last 7 days (812)
Last 30 days (3101)
Last 365 days (28532)
2026 (11714)
2025 (28802)
2024 (32468)
2023 (36611)
2022 (46982)
2021 (51857)
2020 (50980)
2019 (45000)
2018 (34358)
2017 (30742)
2016 (30077)
2015 (35416)
2014 (28404)
2013 (24734)
2012 (26023)
2011 (26267)
2010 (24656)
Location
Africa (887)
Alabama (96)
Alaska (7)
Arizona (278)
Arkansas (15)
Asia (40534)
Australia (7097)
California (12135)
Canada (3504)
China (1346)
Colorado (532)
Connecticut (522)
Delaware (392)
Europe (92004)
Florida (1834)
Georgia (414)
Hawaii (3)
Idaho (59)
Illinois (1042)
India (88)
Indiana (542)
Iowa (21)
Japan (507)
Kansas (126)
Kentucky (51)
Louisiana (41)
Maine (79)
Maryland (1460)
Massachusetts (8556)
Michigan (370)
Minnesota (653)
Mississippi (7)
Missouri (154)
Montana (36)
Nebraska (25)
Nevada (133)
New Hampshire (89)
New Jersey (3360)
New Mexico (31)
New York (3308)
North Carolina (1587)
North Dakota (10)
Northern California (6007)
Ohio (381)
Oklahoma (26)
Oregon (42)
Pennsylvania (2391)
Puerto Rico (27)
Rhode Island (42)
South America (1189)
South Carolina (67)
South Dakota (2)
Southern California (4868)
Tennessee (204)
Texas (2005)
United States (43433)
Utah (375)
Vermont (1)
Virginia (309)
Washington D.C. (74)
Washington State (990)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
674,994 Results for "shanghai institute of materia medica simm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection
May 6, 2026
·
2 min read
Press Releases
Transpire Bio Announces Opening of New Satellite R&D Facility in Shanghai, China
April 28, 2026
·
2 min read
Business
Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments
On November 17, 2021, Simcere Pharmaceutical Group Limited announced that the company has reached collaboration agreement with the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, to develop novel antiviral drugs for COVID-19.
November 22, 2021
·
3 min read
Manufacturing
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in China.
March 19, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at MEDICA 2025
November 19, 2025
·
4 min read
Press Releases
CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in Jinshan, Shanghai
February 12, 2026
·
3 min read
Press Releases
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
November 6, 2025
·
3 min read
Press Releases
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
January 21, 2026
·
2 min read
Press Releases
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
February 5, 2026
·
6 min read
Business
Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine
Universe Pharmaceuticals INC today announced that the Company had entered into two strategic cooperation agreements (the “Agreements”) with Jiangxi Province Institute of Materia Medica.
January 4, 2022
·
4 min read
1 of 67,500
Next
